Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

That differentiates it from another start-up that emerged from the DeepMind team, Hassabis-led Isomorphic Labs, which is working on AlphaFold3 and is focusing on developing a broad range of ...

This week, Mint unlocks Perplexity Labs—an AI-powered tool that can turn messy user feedback into clear, actionable insights.

Meta Platforms Inc. is reportedly establishing a new, secretive artificial intelligence research lab dedicated to achieving “superintelligence, ” a hypothetical AI system that surpasses human ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...